152 related articles for article (PubMed ID: 21385322)
21. Effect of
Moshetova LK; Soshina MM; Turkina KI; Grishina EA; Sozaeva ZA; Kachanova AA; Akmalova KA; Ivashchenko DV; Zastrozhin MS; Fisenko VP; Sychev DA
Drug Metab Pers Ther; 2023 Jun; 38(2):143-148. PubMed ID: 36001461
[TBL] [Abstract][Full Text] [Related]
22. Interaction between timolol eyedrops and oral nicardipine or oral diltiazem in healthy Japanese subjects.
Yatsuka YI; Tsutsumi K; Kotegawa T; Nakamura K; Nakano S; Nakatsuka K
Eur J Clin Pharmacol; 1998 Apr; 54(2):149-54. PubMed ID: 9626919
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
[TBL] [Abstract][Full Text] [Related]
24. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
25. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
[TBL] [Abstract][Full Text] [Related]
26. beta-Blockers and the eye: an overview.
Katz IM
Ann Ophthalmol; 1978 Jul; 10(7):847-50. PubMed ID: 28061
[TBL] [Abstract][Full Text] [Related]
27. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
Urtti A; Rouhiainen H; Kaila T; Saano V
Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
[TBL] [Abstract][Full Text] [Related]
28. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
29. Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate.
Roy K; Mondal KK; Ray B; Chakraborty S; Biswas S; Baral BK
Indian J Ophthalmol; 2012; 60(2):105-7. PubMed ID: 22446904
[TBL] [Abstract][Full Text] [Related]
30. [The effect of timolol eye drops on the intraocular pressure in simple glaucoma (author's transl)].
Krieglstein GK
Klin Monbl Augenheilkd; 1978 May; 172(5):677-85. PubMed ID: 672089
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
Gelatt KN; Larocca RD; Gelatt JK; Strubbe DT; MacKay EO
Am J Vet Res; 1995 Oct; 56(10):1325-31. PubMed ID: 8928950
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
Svec AL; Strosberg AM
Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
[TBL] [Abstract][Full Text] [Related]
33. Resistance to blood flow in the rabbit ophthalmic artery after topical treatment with timolol.
Liu JH; Li R; Nelson TR; Weinreb RN
J Ocul Pharmacol Ther; 2007 Apr; 23(2):103-9. PubMed ID: 17444797
[TBL] [Abstract][Full Text] [Related]
34. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
Agarwal HC; Gupta V; Sihota R
J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
[TBL] [Abstract][Full Text] [Related]
36. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
Nygaard HA; Høvding G
Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
[TBL] [Abstract][Full Text] [Related]
37. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
Schmidt KG; von Rückmann A; Becker R; Pillunat LE
Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of silicone punctal plugs as adjuncts to topical pharmacotherapy of glaucoma--a pilot study. Punctal Plugs in Glaucoma Study Group.
Bartlett JD; Boan K; Corliss D; Gaddie IB
J Am Optom Assoc; 1996 Nov; 67(11):664-8. PubMed ID: 8979659
[TBL] [Abstract][Full Text] [Related]
40. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
Razeghinejad MR; Sawchyn AK; Katz LJ
Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
